Cargando…

Evidences showing wide presence of small genomic aberrations in chronic lymphocytic leukemia

BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western population. Although genetic factors are considered to contribute to CLL etiology, at present genomic aberrations identified in CLL are limited compared with those identified in other types of leukemia, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yeong C, Jung, Yong-Chul, Chen, Jun, Alhasan, Ali H, Kaewsaard, Parawee, Zhang, Yanming, Ma, Shuo, Rosen, Steve, Wang, San Ming
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016268/ https://www.ncbi.nlm.nih.gov/pubmed/21172017 http://dx.doi.org/10.1186/1756-0500-3-341

Ejemplares similares

NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
por: Rosati, Emanuela, et al.
Publicado: (2018)

The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
por: Schieber, Michael, et al.
Publicado: (2019)

Chronic lymphocytic leukemia at ASH 2017
por: Wanner, David, et al.
Publicado: (2018)

Cytogenetic aberrations in adult acute lymphoblastic leukemia—A population‐based study
por: Bergfelt Lennmyr, Emma, et al.
Publicado: (2021)

Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy
por: Handunnetti, Sasanka, et al.
Publicado: (2021)

Inside the chronic lymphocytic leukemia cell: miRNA and chromosomal aberrations
por: Grenda, Anna, et al.
Publicado: (2022)

Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia
por: Tuscano, Joseph, et al.
Publicado: (2020)

Agony of choice—selecting chronic lymphocytic leukemia treatment in 2022
por: Bohn, Jan-Paul
Publicado: (2022)

Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia
por: Samassekou, Oumar, et al.
Publicado: (2013)

High-resolution analysis of aberrant regions in autosomal chromosomes in human leukemia THP-1 cell line
por: Adati, Naoki, et al.
Publicado: (2009)

Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance
por: St-Pierre, Frédérique, et al.
Publicado: (2022)

NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells
por: Di Ianni, Mauro, et al.
Publicado: (2018)

Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks
por: Mallm, Jan‐Philipp, et al.
Publicado: (2019)

17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia
por: Bagacean, Cristina, et al.
Publicado: (2019)

TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
por: Campo, Elias, et al.
Publicado: (2018)

Aberrant histone modification in CD19(+) B cells of patients with chronic lymphocytic leukemia
por: Zhou, Keshu, et al.
Publicado: (2017)

Various inclusions in chronic lymphocytic leukemia/small lymphocytic lymphoma
por: Galiacho, Verónica Roldán, et al.
Publicado: (2022)

Cardiac Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
por: Robak, Tadeusz, et al.
Publicado: (2022)

Next‐generation sequencing reveals the presence of DDX41 mutations in acute lymphoblastic leukemia and aplastic anemia
por: Zhang, Yang, et al.
Publicado: (2021)

Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation
por: Takahashi, Naoto, et al.
Publicado: (2012)

Milestones in Chronic Lymphocytic Leukemia: An exciting decade of progress—10th anniversary of memo
por: Egle, Alexander
Publicado: (2017)

Markers typed in genome-wide analysis identify regions showing deviation from Hardy-Weinberg equilibrium
por: Vine, Anna E, et al.
Publicado: (2009)

Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort
por: Miao, Yi, et al.
Publicado: (2023)

Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma
Publicado: (1990)

The t(11;14)(q13;q32)/CCND1–IGH translocation in chronic lymphocytic leukaemia/small lymphocytic lymphoma: an unusual genetic aberration during the natural clinical course
por: Liu, Ying, et al.
Publicado: (2019)

Chromosomal aberrations detected by Fluorescence in situ hybridization in 344 Brazilian chronic lymphocytic leukemia patients
por: Zorovich, Maria Eduarda Sanseverino de Lourenço da Motta, et al.
Publicado: (2017)

Relationship between Chromosomal Aberrations and Gene Expressions in the p53 Pathway in Chronic Lymphocytic Leukemia
por: Öztan, G, et al.
Publicado: (2020)

New Recurrent Structural Aberrations in the Genome of Chronic Lymphocytic Leukemia Based on Exome-Sequencing Data
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2019)

Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia
por: Klapp, Vanessa, et al.
Publicado: (2023)

Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia with Chromothripsis in an Old Woman
por: Tan, Li, et al.
Publicado: (2015)

Leishmania in a Patient with Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
por: Nicolas, Gregory, et al.
Publicado: (2018)

Pathology of Seminoma Coinciding With Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
por: Bui, Katherine M, et al.
Publicado: (2021)

Neutrocyte-to-lymphocyte ratio predicts the presence of a replicative hepatitis C virus strand after therapy with direct-acting antivirals
por: Wróblewska, Anna, et al.
Publicado: (2019)

Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis
por: Kolquist, Kathryn A, et al.
Publicado: (2011)

Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
por: Odetola, Oluwatobi, et al.
Publicado: (2023)

TET2 Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence of TET2 Variations
por: Hernández-Sánchez, María, et al.
Publicado: (2014)

Aberrant Wnt Signaling in Leukemia
por: Staal, Frank J. T., et al.
Publicado: (2016)

Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations
por: Ondroušková, Eva, et al.
Publicado: (2022)

Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia
por: Domínguez-Berrocal, Leticia, et al.
Publicado: (2016)

Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells
por: Rozovski, Uri, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r5ek6mjagnqmpgdkhas88oe7ap